FGF21 and metabolic disease: In addition to FGF21 analogs, the FGFR1/β-klotho complex (FGF21 receptor agonists, FGF21RAs) opened a new door for aging-associated metabolic diseases, which have been tested in non-human primates (NHPs) and humans (138, 139).